These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23563478)

  • 1. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.
    Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG
    J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
    Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
    J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.
    Fiorella D; Turan TN; Derdeyn CP; Chimowitz MI
    J Neurointerv Surg; 2009 Jul; 1(1):35-9. PubMed ID: 21994103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
    Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
    Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS.
    Miao Z; Song L; Liebeskind DS; Liu L; Ma N; Wang Y; Mo D; Gao F; Zhao X; Dong K; Zhang D; Gao P
    J Neurointerv Surg; 2015 May; 7(5):331-5. PubMed ID: 24759694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of stenting for intracranial atherosclerosis in the post-SAMMPRIS era.
    Ding D; Starke RM; Crowley RW; Liu KC
    Biomed Res Int; 2013; 2013():304320. PubMed ID: 24350256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice.
    Siddiq F; Chaudhry SA; Khatri R; Rodriguez GJ; Tummala R; Suri MF; Qureshi AI
    Neurosurgery; 2012 Jul; 71(1):68-73. PubMed ID: 22382209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
    Mekonnen EA; Tekle WG; Desai SK; Hassan AE
    Interv Neuroradiol; 2023 Aug; 29(4):459-465. PubMed ID: 35331035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    J Neuroimaging; 2009 Oct; 19 Suppl 1():1S-10S. PubMed ID: 19807850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Advances in Endovascular Treatment of Intracranial Atherosclerotic Disease and Future Prospective.
    Jafari M; Nguyen TN; Ortega-Gutierrez S; Hussain MS; Hassan AE; Ikram A; Eliyas JK; Rodriguez GJ; Divani AA
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105556. PubMed ID: 33360252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology.
    Yu SC; Cheng HK; Cheng PW; Lui WM; Leung KM; Tan CB; Pang KY; Wong GK; Cheung YL; Lee R; Wong YC; Wong CK; Kwok JC;
    Hong Kong Med J; 2013 Feb; 19(1):69-73. PubMed ID: 23378358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow failure from intracranial atherosclerotic disease: a rationale for endovascular intervention in a population with recurrent symptoms despite maximal medical therapy.
    Fargen KM; Velat GJ; Lawson MF; Khanna AY; Hoh B; Mocco J
    J Neurointerv Surg; 2013 Jul; 5(4):e17. PubMed ID: 22661599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
    Marks MP
    Stroke; 2012 Feb; 43(2):580-4. PubMed ID: 22246690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure.
    Samaniego EA; Tari-Capone F; Linfante I; Silva CF; Spilberg G; Gounis M; Wakhloo AK; Dabus G
    J Neurointerv Surg; 2013 Jul; 5(4):302-5. PubMed ID: 22544819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial atherosclerosis update for neurointerventionalists.
    Alexander MJ; Yu W
    J Neurointerv Surg; 2024 Apr; 16(5):522-528. PubMed ID: 37295944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular management of intracranial atherosclerosis.
    Teleb MS; Asif K; Castonguay AC; Zaidat OO
    Neurosurg Clin N Am; 2014 Jul; 25(3):593-605. PubMed ID: 24994093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial.
    Quintero-Consuegra MD; Toscano JF; Babadjouni R; Nisson P; Kayyali MN; Chang D; Almallouhi E; Saver JL; Gonzalez NR
    Neurosurgery; 2021 Mar; 88(4):E312-E318. PubMed ID: 33469657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.
    Leung TW; Yu SC; Wong KS
    Int J Stroke; 2011 Aug; 6(4):312-4. PubMed ID: 21745340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.